Status:
UNKNOWN
Progressive Web App About Individualized Patient Decision Aid for NSCLC Stage I-II
Lead Sponsor:
Maastricht University
Conditions:
Lung Cancer Stage I
Lung Cancer Stage II
Eligibility:
All Genders
21-100 years
Brief Summary
Studies indicate that the majority of early-stage non-small cell lung cancer (NSCLC) patients find it important to be involved in treatment decision making. However, in a recent study it has been repo...
Detailed Description
A pilot study in which semi-structured interviews will be conducted (Qualitative research).In addition, patients will be asked to fill in a questionnaire about the usability of the prototype. A small ...
Eligibility Criteria
Inclusion
- Early stage non-small cell lung patients, Treated with curative intent minimum 6 month ago, max 5 years. Doctors IT
Exclusion
- Others
Key Trial Info
Start Date :
October 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2022
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04375566
Start Date
October 4 2021
End Date
February 28 2022
Last Update
August 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iva Halilaj
Maastricht, Limburg, Netherlands